BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15712176)

  • 21. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
    Andreesen R; Brugger W; Löhr GW; Bross KJ
    Am J Pathol; 1989 Jan; 134(1):187-92. PubMed ID: 2536522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The origin and clonal proliferation of malignant altered cells in Hodgkin's disease].
    Krizanac-Bengez L; Boranic M
    Lijec Vjesn; 1990; 112(1-2):50-2. PubMed ID: 2366621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of cell adhesion molecules associated with germinal center in Hodgkin's disease: an immunohistochemical study. The germinal center related complex and histologic subtypes.
    Ree HJ; Khan AA; Qureshi MN; Teplitz C
    Cancer; 1994 Feb; 73(4):1257-63. PubMed ID: 7906194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
    Hansmann ML; Stein H; Dallenbach F; Fellbaum C
    Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hodgkin's disease and non-Hodgkin's lymphoma occurring simultaneously].
    Bosch F; Ordi J; López-Guillermo A; Campo E; Montserrat E; Rozman C
    Med Clin (Barc); 1993 May; 100(20):788-90. PubMed ID: 8321056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy?
    Sundeen JT; Cossman J; Jaffe ES
    Am J Surg Pathol; 1988 Aug; 12(8):599-606. PubMed ID: 3041849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distinction of Hodgkin's disease from T cell lymphoma.
    Banks PM
    Semin Diagn Pathol; 1992 Nov; 9(4):279-83. PubMed ID: 1480849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-chain mRNA in lymphocyte-predominant and mixed-cellularity Hodgkin's disease.
    von Wasielewski R; Wilkens L; Nolte M; Werner M; Georgii A
    Mod Pathol; 1996 Mar; 9(3):334-8. PubMed ID: 8685237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas.
    Gustmann C; Altmannsberger M; Osborn M; Griesser H; Feller AC
    Am J Pathol; 1991 Jun; 138(6):1413-22. PubMed ID: 1711289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
    Strauchen JA; Breakstone BA
    Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous pyrogen production by Hodgkin's disease and human histiocytic lymphoma cell lines in vitro.
    Bodel P; Ralph P; Wenc K; Long JC
    J Clin Invest; 1980 Feb; 65(2):514-8. PubMed ID: 6985918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytokines and malignant lymphomas].
    Feller AC; Merz H
    Verh Dtsch Ges Pathol; 1992; 76():70-8. PubMed ID: 1283279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel monoclonal antibody (FUN-1) identifies an activation antigen in cells of the B-cell lineage and Reed-Sternberg cells.
    Nozawa Y; Wachi E; Tominaga K; Abe M; Wakasa H
    J Pathol; 1993 Mar; 169(3):309-15. PubMed ID: 8492223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
    Weiss LM; Yousem SA; Warnke RA
    Am J Surg Pathol; 1985 Jul; 9(7):480-90. PubMed ID: 3879107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.